drugset / Trial / NCT02222129
Efficacy of Liposomal Bupivacaine Versus 0.25% Bupivacaine for Laparoscopic Urologic Surgery
RandomizedParallel-groupSingle-blindTreatment
Summary
A prospective, randomized comparison of bupivacaine to liposomal bupivacaine given by local injection at all the wound sites in patients undergoing robotic-assisted or laparoscopic urologic surgeries in an effort to determine which method reduced postoperative opioid use the most.
Timeline
- Start
- 2012-12
- Primary completion
- 2013-12
- Completion
- 2013-12
Outcome
Missed primary endpoint
registry Bupivacaine vs Liposomal Bupivacaine; p = 0.39; Wilcoxon (Mann-Whitney) NCT02222129 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Subject | Bupivacaine | Other / unclassified | — | Other |
Indications
No indication recorded.